GLPwatch
Trials (2036)
Page 16 of 34.
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
- Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
- Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
- Young Adults With Early-onset Obesity Treated With Semaglutide
- Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
- SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer (Phase 1)
- A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
- Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
- Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)
- The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
- The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
- Daily Liraglutide for Nicotine Dependence
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice
- The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity
- Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes
- Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)
- Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
- Intravenous Exenatide (Byetta) During Surgery
- Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
- A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
- Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet
- A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes
- Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects
- A Research Study Looking at New Protein-based Tablets in Healthy Male Participants
- The Evira Study: Additional Support During Obesity Treatment
- Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
- Metabolism and Excretion of Liraglutide in Healthy Male Volunteers
- Liver and Fat Regulation in Overweight Adolescent Girls
- Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome
- Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury
- Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus
- Diabetes Islet Preservation Immune Treatment
- A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
- The POST-ACS Study
- Effect of Tirzepatide on Brown Adipose Tissue in Obesity
- Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes
- Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients
- Blood Pressure Outcomes With Liraglutide Therapy
- Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
- A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes
- A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
- A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)
- A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes
- Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
- AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)
- A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
- A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese
- A Study of Tirzepatide in Overweight and Very Overweight Participants
- Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy
- A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
- A Study of Two Different Formulations of LY3502970 in Healthy Participants
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)
- The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
- Effect of Exenatide on Cortisol Secretion
- Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)
- The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus
- Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss